You will be redirected back to your article in seconds

Inside move: Stewart cancels ‘Early’ date

Hostess mauls cabbage, sez she will be cleared

It’s getting a little too hot in the kitchen for Martha Stewart.

Still under fire for selling $227,824 worth of ImClone stock the day before the company’s cancer drug was rejected by the Food and Drug Administration, Stewart opted to cancel her Wednesday appearance on CBS’ “The Early Show.”

That Dec. 27 stock sale has been the recipe for a flurry of negative press regarding Stewart, as congressional investigators check out any prospect of insider trading.

The goddess of all things domestic showed up for her “Early Show” stint last week, but anchor Jane Clayson subjected her to a flurry of questions regarding the ImClone stock sale.

In one of this year’s most bizarre TV moments, Stewart — with sharp knife in hand — frantically chopped a cabbage head while telling Clayson she would be exonerated of any “ridiculousness.” Asked further about the charges, Stewart said she wanted to focus on her salad.

Stewart’s syndicated “Martha Stewart Living” strip continues to air on most CBS-owned stations. It’s unclear when Stewart might opt to return to her regular stint on the “Early Show.” A CBS News spokesperson was unavailable for comment.

More TV

  • Into The Dark -- "The Body"

    TV Review: 'Into the Dark: The Body' on Hulu

    It’s getting a little too hot in the kitchen for Martha Stewart. Still under fire for selling $227,824 worth of ImClone stock the day before the company’s cancer drug was rejected by the Food and Drug Administration, Stewart opted to cancel her Wednesday appearance on CBS’ “The Early Show.” That Dec. 27 stock sale has […]

  • Bob Greenblatt, chairman of NBC EntertainmentPaley

    Bob Greenblatt Poised to Step Down as NBC Entertainment Chairman (EXCLUSIVE)

    It’s getting a little too hot in the kitchen for Martha Stewart. Still under fire for selling $227,824 worth of ImClone stock the day before the company’s cancer drug was rejected by the Food and Drug Administration, Stewart opted to cancel her Wednesday appearance on CBS’ “The Early Show.” That Dec. 27 stock sale has […]

  • New Report Alleges NBC News Chief

    NBC News Chief Andy Lack Faces Scrutiny Over Handling of Sexual Harassment Claims

    It’s getting a little too hot in the kitchen for Martha Stewart. Still under fire for selling $227,824 worth of ImClone stock the day before the company’s cancer drug was rejected by the Food and Drug Administration, Stewart opted to cancel her Wednesday appearance on CBS’ “The Early Show.” That Dec. 27 stock sale has […]

  • RuPaul

    TV News Roundup: RuPaul's Netflix Comedy 'AJ and the Queen' Adds 4 Cast Members

    It’s getting a little too hot in the kitchen for Martha Stewart. Still under fire for selling $227,824 worth of ImClone stock the day before the company’s cancer drug was rejected by the Food and Drug Administration, Stewart opted to cancel her Wednesday appearance on CBS’ “The Early Show.” That Dec. 27 stock sale has […]

  • Jon Huertas and Chris Sullivan

    'This Is Us' Bosses Talk Toby and Miguel Centric Episodes and Filming in Vietnam

    It’s getting a little too hot in the kitchen for Martha Stewart. Still under fire for selling $227,824 worth of ImClone stock the day before the company’s cancer drug was rejected by the Food and Drug Administration, Stewart opted to cancel her Wednesday appearance on CBS’ “The Early Show.” That Dec. 27 stock sale has […]

  • Justin Theroux'Maniac' TV Show premiere, London,

    Justin Theroux Binge-Watched 'The Hills' While Making Netflix's 'Maniac'

    It’s getting a little too hot in the kitchen for Martha Stewart. Still under fire for selling $227,824 worth of ImClone stock the day before the company’s cancer drug was rejected by the Food and Drug Administration, Stewart opted to cancel her Wednesday appearance on CBS’ “The Early Show.” That Dec. 27 stock sale has […]

  • Cary Fukunaga Maniac

    Cary Fukunaga Says He Wouldn't Return to Direct 'Maniac' Season 2

    It’s getting a little too hot in the kitchen for Martha Stewart. Still under fire for selling $227,824 worth of ImClone stock the day before the company’s cancer drug was rejected by the Food and Drug Administration, Stewart opted to cancel her Wednesday appearance on CBS’ “The Early Show.” That Dec. 27 stock sale has […]

More From Our Brands

Access exclusive content